Marksans Pharma shines on reporting 44% rise in Q3 consolidated net profit

08 Feb 2019 Evaluate

Marksans Pharma is currently trading at Rs. 26.40, up by 1.15 points or 4.55% from its previous closing of Rs. 25.25 on the BSE.

The scrip opened at Rs. 25.25 and has touched a high and low of Rs. 26.85 and Rs. 24.75 respectively. So far 326516 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 42.70 on 12-Feb-2018 and a 52 week low of Rs. 22.85 on 06-Feb-2019.

Last one week high and low of the scrip stood at Rs. 26.85 and Rs. 22.85 respectively. The current market cap of the company is Rs. 1025.33 crore.

The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 4.09% and 47.66% respectively.

Marksans Pharma has reported a 2-fold jump in its net profit at Rs 11.78 crore for the quarter ended December 31, 2018 as compared to Rs 5.62 crore for the same quarter in the previous year. Total income of the company increased by 56.58% at Rs 125.31 crore for Q3FY19 as compared Rs 80.03 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 43.93% in its net profit at Rs 25.13 crore for the quarter under review as compared to Rs 17.46 crore for the same quarter in the previous year. Total income of the company increased by 13.57% at Rs 248.52 crore for Q3FY19 as compared Rs 218.82 crore for the corresponding quarter previous year.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×